MedCity Influencers

When a cheaper drug hurts innovation (Best of MedCitizens)

Every week, MedCity News highlights the best of its MedCitizens: syndication partners and MedCity News readers who discuss life science current events on MedCityNews.com. Now here’s the best of what YOU had to say.

Every week, MedCity News highlights the best of its MedCitizens: syndication partners and MedCity News readers who discuss life science current events on MedCityNews.com.

Now here’s the best of what YOU had to say:

When cheaper isn’t better: The case of Avastin, Lucentis and wet AMD. “I’m a big fan of cost containment in health care. But I’m dead set against using a $50 shot of Avastin in place of a $2000 shot of Lucentis even if safety and efficacy are the same. Why? Because it has a chilling effect on innovation.”

Obamacare to blame for rising insurance premiums? Not so fast. “The private insurance industry is covering fewer people and facing just a 4 percent increase in costs. Yet it is raising premiums 9 percent. No wonder profits are rising smartly.”

The 10 Cs you need to lead an emerging medtech company. “There have been many books, articles and probably blogs written about what it takes to corner the corner office. When that corner office is overlooking the HVAC system of a sub-sub-leased space crammed with tired-looking engineers, low-paid summer interns, 3 day old pizza, EBAY-purchased testing devices, duct tape covered chairs, and the strewn parts of multiple cannibalized pieces of equipment, otherwise known as a start-up med tech company, different rules apply.”

HBV, HCV targeted in new organ transplant guidelines. There have been several cases of HIV or hepatitis transmitted via solid organ transplantation. The CDC is recommending new guidelines which would replace the 1994 Public Health Service (PHS) Guidelines for Preventing Transmission of HIV through Transplantation of Human Tissue and Organs.

Health 2.0 Code-a-thon sends IT innovators scrambling. “I spent the much of the weekend at a special event preceding this year’s Health 2.0 conference in San Francisco that started last night. This was the Health 2.0 Developer Challenge Code-a-thon. I made a short presentation on Saturday and got asked to be a judge on Sunday. The event runs for two days and all the coders there are running on fumes and have caffeine tremors but rally amazingly to come up with great code and solutions.”

This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.

Topics